The mesothelial cell

被引:271
作者
Mutsaers, SE [1 ]
机构
[1] Univ Western Australia, Royal Perth Hosp, Dept Surg, Perth, WA 6000, Australia
[2] Sir Charles Gairdner Hosp, Asthma & Allergy Res Inst, Nedlands, WA 6009, Australia
关键词
serosa; inflammation; tissue repair; fibrinolysis; adhesions; malignant mesothelioma;
D O I
10.1016/S1357-2725(03)00242-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mesothelial cells form a monolayer of specialised pavement-like cells that line the body's serous cavities and internal organs. The primary function of this layer, termed the mesothelium, is to provide a slippery, non-adhesive and protective surface. However, mesothelial cells play other pivotal roles involving transport of fluid and cells across the serosal cavities, antigen presentation, inflammation and tissue repair, coagulation and fibrinolysis and tumour cell adhesion. Injury to the mesothelium triggers events leading to the migration of mesothelial cells from the edge of the lesion towards the wound centre and desquamation of cells into the serosal fluid which attach and incorporate into the regenerating mesothelium. If healing is impaired, fibrous serosal adhesions form between organs and the body wall which impede vital intrathoracic and abdominal movement. Neoplastic transformation of mesothelial cells gives rise to malignant mesothelioma, an aggressive tumour predominantly of the pleura. Although closely associated with exposure to asbestos, recent studies have implicated other factors including simian virus 40 (SV40) in its pathogenesis. (C) 2003 Elsevier Ltd. All rights reserved.
引用
收藏
页码:9 / 16
页数:8
相关论文
共 20 条
[1]   Adhesion molecule-dependent mechanisms regulate the rate of macrophage clearance during the resolution of peritoneal inflammation [J].
Bellingan, GJ ;
Xu, P ;
Cooksley, H ;
Cauldwell, H ;
Shock, A ;
Bottoms, S ;
Haslett, C ;
Mutsaers, SE ;
Laurent, GJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (11) :1515-1521
[2]  
Cerrano PG, 2003, INT J ONCOL, V22, P187
[3]   GASTROINTESTINAL MALIGNANCY - RATIONALE FOR ADJUVANT THERAPY USING EARLY POSTOPERATIVE INTRAPERITONEAL CHEMOTHERAPY [J].
CUNLIFFE, WJ ;
SUGARBAKER, PH .
BRITISH JOURNAL OF SURGERY, 1989, 76 (10) :1082-1090
[4]   IMMUNOCYTOCHEMICAL TYPIFICATION OF MESOTHELIAL CELLS IN EFFUSIONS - IN-VIVO AND IN-VITRO MODELS [J].
FERRANDEZIZQUIERDO, A ;
NAVARROFOS, S ;
GONZALEZDEVESA, M ;
GILBENSO, R ;
LLOMBARTBOSCH, A .
DIAGNOSTIC CYTOPATHOLOGY, 1994, 10 (03) :256-262
[5]  
Foley-Comer AJ, 2002, J CELL SCI, V115, P1383
[6]   Accessory role of human peritoneal mesothelial cells in antigen presentation and T-cell growth [J].
Hausmann, MJ ;
Rogachev, B ;
Weiler, M ;
Chaimovitz, C ;
Douvdevani, A .
KIDNEY INTERNATIONAL, 2000, 57 (02) :476-486
[7]  
Holmdahl L, 1997, EUR J SURG, V163, P24
[8]  
JONES LMH, 1995, CLIN EXP METASTAS, V13, P373
[9]  
Liberek T, 1996, J AM SOC NEPHROL, V7, P208
[10]   Stimulation of mesothelial cell proliferation by exudate macrophages enhances serosal wound healing in a murine model [J].
Mutsaers, SE ;
Whitaker, D ;
Papadimitriou, JM .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (02) :681-692